Structure-based design of irreversible human rhinovirus 3C protease inhibitors.

被引：0

作者：

Dragovich, PS ^{[1
]}

Webber, SE ^{[1
]}

Babine, RE ^{[1
]}

Fuhrman, SA ^{[1
]}

Patick, AK ^{[1
]}

Matthews, DA ^{[1
]}

Reich, SH ^{[1
]}

Prins, TJ ^{[1
]}

Marakovits, JT ^{[1
]}

Littlefield, ES ^{[1
]}

Zhou, R ^{[1
]}

Tikhe, J ^{[1
]}

Ford, CE ^{[1
]}

Wallace, MB ^{[1
]}

Bleckman, TM ^{[1
]}

Meador, JW ^{[1
]}

Ferre, RA ^{[1
]}

Brown, EL ^{[1
]}

Binford, SL ^{[1
]}

DeLisle, DM ^{[1
]}

Worland, ST ^{[1
]}

机构：

[1] Agouron Pharmaceut Inc, San Diego, CA 92121 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 215卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

011-MEDI

引用

页码：U863 / U863

页数：1

共 50 条

[31] Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides
Dragovich, PS
Zhou, R
Skalitzky, DJ
Fuhrman, SA
Patick, AK
Ford, CE
Meador, JW
Worland, ST
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (04) : 589 - 598
[32] Synthesis and evaluation of tripeptidyl α-ketoamides as human rhinovirus 3C protease inhibitors
Chen, SH
Lamar, J
Victor, F
Snyder, N
Johnson, R
Heinz, BA
Wakulchik, M
Wang, QM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) : 3531 - 3536
[33] STRUCTURE-BASED DESIGN OF CALCINEURIN INHIBITORS.
Kissinger, Charles R.
Parge, Hans
Knighton, Daniel
Pelletier, Laura
Tempczyk, Anna
Tatlock, John
Villafranca, Ernest
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C201 - C201
[34] Structure-based design of ricin inhibitors.
Kerwin, SM
Ravikumar, KS
Miller, D
Robertus, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U54 - U54
[35] Non-covalent inhibitors of rhinovirus 3C protease
Baxter, Andrew
Chambers, Mark
Edfeldt, Fredrik
Edman, Karl
Freeman, Adrian
Johansson, Cristian
King, Sarah
Morley, Andy
Petersen, Jens
Rawlins, Phil
Spadola, Loredana
Thong, Bob
Van de Poel, Herve
Williams, Nicola
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 777 - 780
[36] Inhibition of human rhinovirus 3C protease by homophthalimides
Jungheim, LN
Cohen, JD
Johnson, RB
Villarreal, EC
Wakulchik, M
Loncharich, RJ
Wang, QM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (12) : 1589 - 1594
[37] Structure-based drug design and the evaluation of irreversible HCV-protease inhibitors
Qiao, Lixin
Niu, Deqiang
Zhu, Zhendong
Labenski, Matt
Hagel, Margit
St Martin, Thia
Sheet, Michael
Bernard, Hugues
Nacht, Mariana
Westlin, Willian
Petter, Russell
Singh, Juswinder
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[38] S-nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease
Xian, M
Wang, QM
Chen, XC
Wang, K
Wang, PG
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) : 2097 - 2100
[39] A HIGH-CAPACITY MICROBIAL SCREEN FOR INHIBITORS OF HUMAN RHINOVIRUS PROTEASE 3C
MCCALL, JO
KADAM, S
KATZ, L
BIO-TECHNOLOGY, 1994, 12 (10): : 1012 - 1016
[40] Activation of human rhinovirus-14 3C protease
Wang, QM
Johnson, RB
VIROLOGY, 2001, 280 (01) : 80 - 86

← 1 2 3 4 5 →